High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT

M. Hengeveld,S Suciu,Y. Chelgoum,J.P. Marie,P. Muus,François Lefrère,Franco Mandelli,F. Pane,S Amadori,G. Fioritoni,Boris Labar,Frédéric Baron,Jaroslav Cermak,Bourhis Jh,G. Storti,Paola Fazi,A. Hagemeijer,Marco Vignetti,R. Willemze,T.J.M. de Witte

High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT

2015

High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT

Keywords:

Diabetes mellitus
Immunology
Progenitor cell
Graft-versus-host disease
Stem cell
CD34
Medicine
Peripheral
Transplantation
Leukemia
Randomization
Hazard ratio
Confidence interval

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations